Interventional cardiologist @umichCVC: Low-risk approval for #TAVR is a "momentous event" that's "completely transformed the way we treat people with aortic stenosis"
"Today is a momentous event that crowns an epic journey that has completely transformed the way we treat people with aortic stenosis.
People now have all options available and it gives us all an immense responsibility to ensure that we can deliver it to them in the safest way and with the best outcomes.
We are also entrusted with the responsibility to ensure that the technology is not abused, and to follow patients for a long time to ensure that the long term outcomes are just as good."
- Stanley J Chetcuti, M.D.
Interventional cardiologist at Michigan Medicine's (University of Michigan) Frankel Cardiovascular Center
Director, Cardiac Catheterization Laboratory
Co-author on EVOLUT trial
*Feel free to use above quote or contact for interview with a specialist at Michigan Medicine's Frankel Cardiovascular Center